Synthesis Theta

The recipe for efficiency by Universal Pack
The remote installation of a complete packaging line for 4-side-seal sachets has just ended. The pharmaceutical multinational company chose Universal Pack mainly for the high output in terms of cartons/minute, the possibility of compacting the sachets stack with ad hoc systems, the maximum flexibility in formats and reduced blueprint as opposed to competitors’ offer.
The Project
The collaboration between the multinational company and Universal Pack starts with a project concerning the making of a complete packaging line for producing 4-side-seal sachets and automatically inserting them in pre-glued cartons.
The need of the buyer was to adopt a technological solution that would allow maximum production flexibility, high output and compliance with pharmaceutical market requirements, in one solution.
Universal Pack’s answer has satisfied all the specific requests and is structured in the following areas:
The machine speed for 4-side-seal Theta: this vertical machine model allows to reach horizontal machines output, while reducing footprint to a large extent and keeping greater flexibility.
Another key factor in the choice is the compact footprint of the whole line proposed by Universal Pack compared to the equivalent offer by other market players.
The quality in terms of sachets endurance, product integrity and aesthetic beauty produced by Theta machine also affected the decision. The high quality is made possible by a new horizontal sealing concept and a specific liquid cooling system for the sealing parts, avoiding film and product stress during dosing.
Total flexibility in sachet and carton size: this is a key factor especially for contracting companies and companies managing several production batches.
Another reason not to underestimate is the possibility to compact the stacks of sachets before transferring them to the cartoning machine: this process allows to gain greater stability and insert more sachets with equal carton size.
In addition, complying with the goal of operations simplification, adjustments and formats change take place without the need for extra tools.
In order to guarantee the highest precision at any output, the packaging line was equipped with multilane checkweigher, thousandth load cells with direct feedback to the single lanes of the dosing unit. There is also a station for the manual reintegration of rejected sachets.
The extractable dosing system can be placed at ergonomic height to facilitate cleaning operations and format change.
To reduce operational costs while keeping maximum efficiency, it was agreed to provide a completely customized assistance and maintenance plan, including training, on site and remote assistance, predictive maintenance, 4.0.
Remote equipment installation.
10 Advantages of the Project:
• Output speed
• Compact blueprint
• Sachet quality
• Total flexibility in size
• Tool-free adjustments and format change
• Carton volume minimization
• Multilane checkweigher
• Extractable dosing unit
• Operational costs minimization
• Remote plant installation

Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Women in Pharma: Manufacturing personal and team success
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience. -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Trump administration halts global supply of HIV, malaria, tuberculosis drugs
In various memos circulated to the United States Agency for International Development (USAID), the Trump administration has demanded contractors and partners to immediately stop work in supplying lifesaving drugs for HIV, malaria, and tuberculosis to c... -
News 2024 Drug Approvals: a lexicon of notable drugs and clinical trials
50 drugs received FDA approval in 2024. The centre for biologics evaluation and research also identified six new Orphan drug approvals as under Biologics License Applications (BLAs). The following list picks out key approvals from the list, and highlig...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance